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Abstract
Amyloidogenic proteins associated with a variety of unrelated diseases are typically capable of forming several distinct self-
templating conformers. In prion diseases, these different structures, called prion strains (or variants), confer dramatic
variation in disease pathology and transmission. Aggregate stability has been found to be a key determinant of the diverse
pathological consequences of different prion strains. Yet, it remains largely unclear what other factors might account for the
widespread phenotypic variation seen with aggregation-prone proteins. Here, we examined a set of yeast prion variants of
the [RNQ+] prion that differ in their ability to induce the formation of another yeast prion called [PSI+]. Remarkably, we
found that the [RNQ+] variants require different, non-contiguous regions of the Rnq1 protein for both prion propagation
and [PSI+] induction. This included regions outside of the canonical prion-forming domain of Rnq1. Remarkably, such
differences did not result in variation in aggregate stability. Our analysis also revealed a striking difference in the ability of
these [RNQ+] variants to interact with the chaperone Sis1. Thus, our work shows that the differential influence of various
amyloidogenic regions and interactions with host cofactors are critical determinants of the phenotypic consequences of
distinct aggregate structures. This helps reveal the complex interdependent factors that influence how a particular amyloid
structure may dictate disease pathology and progression.
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Introduction
The misfolding of proteins to form cross-b sheet amyloid
structures is characteristic of a variety of diseases, including many
neurodegenerative disorders, such as Alzheimer’s disease [1].
Increasing evidence suggests that these protein conformational
disorders are caused by a similar etiological mechanism, in which
the amyloid that forms represents an infectious, self-templating
structure that is often described as prion-like [2,3]. Prion diseases
are caused when the native form of the prion protein (PrPC)
misfolds and aggregates to form the amyloid structure called PrPSc
[4]. PrPSc is considered infectious because it transmits its
pathogenic conformation by templating the conversion of other
native PrPC monomers to PrPSc in a self-propagating fashion [5].
To add another layer of complexity, it now appears that the
proteins that misfold in these disorders can adopt an array of
different aggregated conformations, called prion strains in prion
diseases [6–8]. Prion strains often have unique biochemical
properties and encode different degrees of infectivity [9]. These
differences are thought to be the underlying cause of the
widespread pathological variation seen in prion diseases. It was
recently shown that distinct self-propagating structures of a-
synuclein, the protein that misfolds in Parkinson’s disease, also
exist and promote the formation of tau inclusions to different
extents [10]. Yet, with estimates that a single amyloidogenic
protein like PrP may propagate over 30 distinct aggregate
conformers [11], it is unclear what underlying factors contribute
to such widespread structural and phenotypic diversity.
A tremendous amount of insight into the physical basis of prion
strains, and amyloid polymorphism in general, has come from
studying the prion strains that are endogenous to the budding
yeast Saccharomyces cerevisiae (here also called prion variants). Like
mammalian amyloidogenic proteins, yeast prion proteins form
self-propagating, b sheet-rich amyloid structures. These self-
perpetuating yeast prions exhibit dominant, non-Mendelian
inheritance that promotes variation in cellular phenotypes [12].
One of the most well-studied yeast prions is the [PSI+] prion,
formed from the translation termination factor Sup35. Sup35 is
soluble and functional in [psi2] cells, but Sup35 misfolds and is
sequestered into prion aggregates in [PSI+] cells, resulting in a
nonsense suppression phenotype [13,14]. Two [PSI+] prion
variants were initially categorized based on the degree of nonsense
suppression [15]. Cells propagating the strong [PSI+] variant
showed increased nonsense suppression relative to cells propagat-
ing the weak [PSI+] variant. Yet, like prion strains of PrPSc, it has
become clear that a large continuum of different [PSI+] variants
also exists [16–18].
Studies of conformationally distinct amyloid fibers of the prion-
forming domain (PFD) of Sup35 formed in vitro have helped reveal
a foundation to explain the structural and phenotypic differences
between [PSI+] variants [19–23]. Like most yeast prions, and even
several disease-associated proteins, Sup35 has a PFD that is rich in
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glutamine and asparagine (Q/N) residues, and is necessary for the
maintenance of [PSI+] [12,15,24–27]. In distinguishing [PSI+]
variants, it was shown that the contiguous length of the Sup35-
PFD that forms the amyloid core correlates with a set of
interdependent biochemical properties, including fiber stability,
average aggregate size, and replication kinetics [19–21,28–30].
Collectively, these parameters dictate a balance between fiber
fragmentation and fiber growth, which is the major biophysical
determinant of the resulting [PSI+] phenotype [20]. In the case of
strong [PSI+] cells, the shorter and more fragile amyloid core of
the Sup35 aggregates gives rise to more fragmentation and greater
sequestration of Sup35 into aggregates, thereby resulting in more
nonsense suppression. The more stable structure of Sup35
aggregates in weak [PSI+] cells, on the other hand, does not as
readily fragment or capture monomer; hence, a larger pool of
functional protein remains to participate in translation termina-
tion. These biochemical parameters have served as the foundation
to describe the structural basis of prion strains, and have been
shown to apply to various PrPSc strains [31,32]. However, these
correlations do not always hold true for the wide variety of
structural variants that are possible for [PSI+], PrPSc, and even
another yeast prion, [RNQ+] [11,33–37]. Thus, it remains a
mystery what other variables help determine the extensive
phenotypic differences exhibited by different prion strains.
Interestingly, while [PSI+] modulates translation termination,
the major phenotypic manifestation of the [RNQ+] prion (also
called [PIN+] and formed from the Rnq1 protein) is inducing the
de novo formation of [PSI+] [38–43]. The formation of [PSI+], but
not its continued propagation, relies on the presence of the [RNQ+
] prion [38]. Five different variants of the [RNQ+] prion have been
categorized based on how frequently they facilitate [PSI+]
formation, from low rates to very high rates [44]. These [RNQ+]
variants were also classified by the aggregate pattern observed in
cells expressing GFP-tagged Rnq1 [45]. Cells predominately
showing one fluorescent focus were called single-dot (s.d.) [RNQ+],
while cells having many foci were called multiple-dot (m.d.) [RNQ+
]. Recently, it was demonstrated that Rnq1 can form over 40
variants of the [RNQ+] prion [33], and different [RNQ+] variants
were also found in wild yeast isolates [46]. While the mechanism of
how [RNQ+] affects [PSI+] formation remains to be elucidated, a
number of studies suggest that [RNQ+] acts as an imperfect
template that interacts with Sup35 to cross-seed the induction of
[PSI+] [47–49]. Indeed, similar to Sup35, Rnq1 has a Q/N-rich
PFD that is necessary for prion propagation and may facilitate the
interaction with Sup35 [42,49,50]. However, while some differ-
ences in biochemical and cellular properties have been noted
between [RNQ+] variants, none of these properties explain how
[RNQ+] variants differentially promote [PSI+] formation
[33,34,44,45,51,52].
Here, we set out to determine what factors distinguish [RNQ+]
prion variants to allow for such dramatic phenotypic differences in
[PSI+] inducibility. We found that each [RNQ+] variant relies on a
distinct set of non-adjacent regions for both propagation and
interaction with Sup35. While there is normally much emphasis
on Q/N-rich prion-like domains, we show that regions outside of
the canonical Rnq1-PFD influence [RNQ+] propagation in a
variant-dependent manner. Furthermore, our data provide
striking support for the hypothesis that different interactions
between amyloid and molecular chaperones, and potentially other
cellular cofactors, influence the phenotypic manifestations of
distinct prion variants. This work helps reveal the structural and
biological complexity underlying prion strains, showing that a
large set of interdependent factors likely contribute to the ability of
distinct aggregate conformations to modulate disease phenotype
and transmissibility.
Results
Fiber fragmentation parameters do not distinguish
[RNQ+] variants
[PSI+] variants are easily distinguished by a set of parameters
that define an equilibrium between fiber growth and fiber
fragmentation [20]. We asked whether these parameters could
similarly distinguish a set of previously published [RNQ+] variants.
This set consisted of four s.d. [RNQ+] variants having [PSI+]
induction levels from low to very high, and one m.d. [RNQ+]
variant with a high level of [PSI+] induction [44]. We first
examined whether differences in the fragmentation of the [RNQ+]
variants could explain the differences in [PSI+] inducibility. The
properties that dictate fragmentation often include aggregate
stability, aggregate size, and chaperone interactions. To test the
stability of the Rnq1 aggregates, we subjected [RNQ+] [psi2] cell
lysates to a gradient of increasing temperature, as different
amyloid conformations can have different melting temperatures
(Tm) [19]. In agreement with previous studies [33,49,51], we found
that only the m.d. high [RNQ+] variant was thermal labile, having
a much lower Tm (,58uC) as compared to the similar Tm (,86uC)
of all the s.d. [RNQ+] variants (Figure 1A). We also analyzed the
sensitivity of Rnq1 aggregates to protease digestion, as work with
the mammalian PrPSc prion has shown that prion strains can
display different sensitivities to digestion with proteinase K (PK)
[9]. Strains of a-synuclein also show different levels of PK
sensitivity [10]. After incubating cell lysates with PK at 37uC, we
again found that only m.d. high [RNQ+] was an outlier in
displaying increased PK resistance as compared to the s.d. [RNQ+]
variants (Figure 1B and Figure S1).
We then analyzed the average size distribution of the Rnq1
aggregates using semi-denaturing agarose gel electrophoresis
(SDD-AGE), which resolves the Rnq1 aggregated species. By
electrophoretically separating the protein longer, we observed
some more distinctions between the [RNQ+] variants than
Author Summary
Protein conformational disorders, including many neurode-
generative diseases, result when a protein misfolds and
undergoes a conformational change to form self-templating
aggregates, called amyloid. Interestingly, the proteins that
misfold in these diseases tend to form a wide variety of
distinct aggregate structures. In prion diseases, these
different amyloid conformations are called prion strains.
The different conformations of prion strains are responsible
for modulating disease progression, pathology, and trans-
mission. Previous work with yeast prions has provided
tremendous insight into how distinct prion conformers can
cause such phenotypic variability. Here, we used a set of
[RNQ+] prion variants to show the complex web of
interactions involved in the propagation of distinct aggre-
gate structures. We found that several different non-
adjacent regions of Rnq1, even outside the prion-forming
domain, make varying contributions to the propagation of
distinct variants of the [RNQ+] prion. Moreover, our data
support the hypothesis that the [RNQ+] variants differen-
tially interact with the molecular chaperone Sis1. These data
strongly suggest that the variable phenotypic manifesta-
tions of different aggregate conformations depend upon a
unique set of primary structural elements and differential
interactions with host cofactors.
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previously described [51]. There was a gradual decrease in
aggregate size between s.d. low, s.d. medium, and s.d. high [RNQ+
] (notice the aggregates of s.d. low [RNQ+] that appear stuck in the
well) (Figure 1C). However, both s.d. very high and m.d. high
[RNQ+] had predominantly larger aggregates.
Another major factor that distinguishes the ability of yeast prion
variants to fragment in vivo is their interaction with chaperones.
Prion replication requires recognition of prion aggregates by the
Hsp40 co-chaperone Sis1 and fragmentation by Hsp104 to create
‘‘seeds’’ (or propagons) that cause further monomeric conversion
to the prion state [12,53]. Sis1 interacts with Rnq1 specifically in
[RNQ+] cells [54] and this interaction is required for propagation
of [RNQ+] [55]. Additionally, more Sis1 is associated with Rnq1
aggregates as compared to Sup35 aggregates [56], which may
suggest that Sis1 plays a more significant role in the propagation of
[RNQ+] as compared to [PSI+]. Therefore, as another measure of
fragmentability, we asked whether the level of Sis1 associated with
Rnq1 differed between [RNQ+] variants. To test this, we
immunoprecipitated Sis1 from [rnq2] cells or cells propagating
the [RNQ+] variants and immunoblotted for Rnq1. While Sis1 did
not co-immunoprecipitate Rnq1 in [rnq2] cells, Sis1 and Rnq1
were similarly associated in all [RNQ+] cells (Figure 1D), in
agreement with a previous study [52]. Furthermore, all the [RNQ+
] variants depended on Sis1 expression to similar levels for their
maintenance (data not shown).
These data do not preclude the possibility that the [RNQ+]
variants are fragmented to different extents. However, they show
that the standard parameters used to monitor fragmentation
neither distinguish the [RNQ+] variants, as they do for [PSI+]
variants, nor correlate to [PSI+] inducibility.
Fiber growth parameters do not explain phenotypic
differences of [RNQ+] variants
In addition to differences in fiber fragmentation, [PSI+] variants
also show differences in fiber growth parameters. Knowing the
functional role of Sup35 in translation termination allows these
differences to be easily monitored phenotypically. The most
common means involves colorimetrically measuring the degree of
nonsense suppression of the ade1-14 allele that has a premature
stop codon in the ADE1 gene [57]. The large soluble pool of
Sup35 in [psi2] cells allows for faithful translation termination at
the premature stop codon. This results in the accumulation of a
metabolic intermediate and incomplete synthesis of adenine,
thereby making these cells unable to grow on medium lacking
adenine, and colonies grown on rich media are red. By contrast,
Sup35 aggregates in strong [PSI+] cells readily recruit and
Figure 1. Biophysical parameters associated with fiber fragmentation do not distinguish [RNQ+] variants. (A) Rnq1 aggregates of s.d.
[RNQ+] variants have similar thermal stability and are more stable than m.d. high [RNQ+]. Lysates were treated with a temperature gradient, followed
by SDS-PAGE and western blot using an aRnq1 antibody. Rnq1 was quantified using ImageJ, normalized to the 100uC band, and plotted using Origin
9.0 software. Data are representative of at least five independent experiments. (B) Rnq1 aggregates of m.d. high [RNQ+] have increased protease
resistance as compared to the s.d. [RNQ+] variants. Lysates of [rnq2] cells or cells propagating the indicated [RNQ+] variant were incubated with 2 mg/
mL proteinase K (PK) at 37uC for 1 hr, followed by SDS-PAGE and western blot with an aRnq1 antibody. (C) Relative Rnq1 aggregate distribution for
each [RNQ+] variant does not correlate to rate of [PSI+] induction. Lysates of yeast cells propagating s.d. low, s.d. medium, s.d. high, s.d. very high, and
m.d. high (m.d.) [RNQ+] were subjected to SDD-AGE and western blot using an aRnq1 antibody. Data are representative of at least three independent
experiments. (D) Co-immunoprecipitation of Sis1 and Rnq1. Sis1 was immunoprecipitated from cell lysates using an aSis1 antibody (gift from E.
Craig), analyzed by SDS-PAGE, and immunoblotted with aRnq1 and aSis1 antibodies. The input of the total cell lysate (I) represents 10% of the sample
that was bound by the aSis1 antibody (B). The bound fraction from the same sample not incubated with antibody (N) was used as a control.
doi:10.1371/journal.pgen.1004337.g001
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sequester soluble Sup35 into aggregates to cause nonsense
suppression [15,58]. Hence, strong [PSI+] cells have less soluble
Sup35, propagate a mitotically stable aggregate structure, and
form light pink or white colonies that grow well on medium
lacking adenine. Weak [PSI+] cells, on the other hand, have an
intermediate phenotype. Thus, the fiber growth characteristics of
[PSI+] variants are often monitored by: mitotic stability, the
amount of soluble protein, and the resulting [PSI+] phenotype.
In contrast to Sup35, the functional role of Rnq1 is not known.
Hence, in order to phenotypically monitor [RNQ+], we previously
developed a chimeric protein called the [RNQ+] Reporter Protein
(RRP) [49], which consists of the Rnq1-PFD(153-405) fused to the
middle and C-terminal domains of Sup35 that provide the
GTPase activity required for translation termination [59]. RRP
allows us to monitor the [RNQ+] prion state by colony color
phenotype in a manner analogous to [PSI+]. RRP is functional in
translation termination in [rnq2] cells that remain red, while it co-
aggregates with Rnq1 in [RNQ+] cells to generate colonies that are
phenotypically pink or white [33,34]. Thus, the [RRP+] pheno-
type, like the [PSI+] phenotype, serves as a measure of the prion
variant-specific sequestration of monomeric protein. Hence, to
examine fiber growth parameters, we first determined the [RRP+]
phenotype for the set of [RNQ+] variants studied in this work.
Interestingly, we found that the three ‘‘higher’’ [RNQ+] variants
had a stronger nonsense suppression phenotype as compared to
s.d. low and s.d. medium [RNQ+] (Figure 2A). Previous work
demonstrated that s.d. very high [RNQ+] cells had the greatest
amount of soluble Rnq1 [44]. Hence, this suggests that, in contrast
to other published [RNQ+] variants [34], the [RRP+] phenotype of
the set of [RNQ+] variants in this study does not correlate to the
level of soluble Rnq1. Moreover, it was surprising that the [RRP+]
phenotype correlated to [PSI+] inducibility for these [RNQ+]
variants, as this was not the case for other [RNQ+] variants
[33,34], or for several other prion properties of [RNQ+] (this work
and [44,51,52]).
The mitotic stability of prion variants is another measure of
fiber growth as this property relies on the degree to which
monomer is sequestered into aggregates. This property has been
shown to distinguish [PSI+] variants and other [RNQ+] variants
[15,33,34]. Hence, to test the mitotic stability of the [RNQ+]
variants, we plated overnight cultures of cells expressing RRP and
propagating each of the [RNQ+] variants onto rich media, and
then counted the number of colonies that were red or had red
sectors (indicating loss of the [RRP+] phenotype and the [RNQ+]
prion). We found that both s.d. low and s.d. very high [RNQ+]
showed higher levels of mitotic loss compared to the other three
[RNQ+] variants (Figure 2B). This loosely correlates with the
amount of soluble Rnq1 present in these cells: s.d. low and s.d.
very high [RNQ+] have been shown to have the greatest amount of
soluble Rnq1 [44]. However, because s.d. low [RNQ+] has less
soluble protein as compared to s.d. very high [RNQ+] [44], we
would have expected s.d. low [RNQ+] to have higher mitotic
stability. Hence, mitotic stability did not correlate to either the
[RRP+] phenotypes or the level of soluble Rnq1 of this set of
[RNQ+] variants, in contrast to what was shown with [PSI+]
variants and other [RNQ+] variants [34,58].
The region outside of the Rnq1-PFD has variant-specific
influence on fiber growth
While regions outside of PFDs remain under-studied, various
work has implicated non-PFD regions as affecting prion propa-
gation [28,60]. Indeed, the N-terminal domain that lies outside of
the putative Rnq1-PFD can influence the propagation of [RNQ+]
[49,61,62]. As such, to gain insight into how the [RNQ+] variants
are physically distinct, we hypothesized that the Rnq1 N-terminal
domain might impact [RNQ+] propagation in a variant-specific
manner. To address this, we used a modified version of RRP
containing full-length (FL) Rnq1 (aa 1-405) fused to the MC
domains of Sup35, in contrast to the original version of RRP that
contained just the Rnq1-PFD (aa 153-405). Using sup35D cells that
were complemented by episomal SUP35, we used a plasmid shuffle
technique to replace Sup35 with plasmids expressing RRP, FL
RRP, or Sup35. Strikingly, FL RRP was not able to functionally
replace Sup35 in cells propagating the m.d. high [RNQ+] variant
(Figure 2C). Importantly, there was no effect on viability when
cells still expressed Sup35. Moreover, the inviability depended on
the presence of both the m.d. high [RNQ+] variant and the Rnq1
protein, as eliminating (curing) the prion or deleting RNQ1 before
replacing Sup35 with FL RRP resulted in viable cells (Figures 2C
and S2). (As expected, the cells were white in the latter case,
indicating that FL RRP propagates the aggregated structure of
m.d. high [RNQ+] in the absence of the Rnq1 protein since FL
Rnq1 is still expressed as part of FL RRP.) In light of previous
work showing that m.d. high [RNQ+] cells have relatively little
soluble Rnq1 [44], these data suggest that the presence of the
Rnq1 N-terminus on FL RRP promotes sequestration of FL RRP
into Rnq1 aggregates to such a large extent that there is too little
soluble FL RRP to function in translation termination. In contrast,
[rnq2] cells and cells propagating each of the s.d. [RNQ+] variants
were viable when expressing FL RRP (Figures 2C and S3). In fact,
cells propagating each of the s.d. [RNQ+] variants and harboring
FL RRP were darker pink as compared to the equivalent cells
expressing RRP, thus indicating that translation termination was
more efficient.
Based on the different phenotypes that resulted from using RRP
versus FL RRP, we wanted to more directly test, without the use of
RRP, whether the Rnq1 N-terminus influenced the ability of
newly synthesized Rnq1 to join pre-existing Rnq1 aggregates. We
used a galactose-inducible promoter to express HA-tagged Rnq1
or Rnq1-PFD in cells that are grown in media containing
galactose. Then we monitored the ability of Rnq1 monomer to
join untagged pre-existing aggregates of the different [RNQ+]
variants using a well-trap assay. This assay allows us to easily
determine the amount of soluble Rnq1 in the cell, as aggregated
Rnq1 is retained in the wells of an SDS-PAGE gel when samples
are not boiled [63]. As expected for [rnq2] cells, upon inducing
expression of HA-Rnq1 or Rnq1-PFD, we found that all pre-
existing and newly synthesized Rnq1 protein was soluble
(Figure 2D). By contrast, all newly synthesized HA-Rnq1 joined
the pre-existing aggregates for each of the [RNQ+] variants, as
indicated by the absence of a band in the unboiled lanes.
Interestingly, we saw variant-specific effects when we expressed
just the Rnq1-PFD. For m.d. high [RNQ+], newly synthesized
Rnq1-PFD, like HA-Rnq1, completely joined the pre-existing
aggregates in the given time duration. All of the s.d. [RNQ+]
variants, on the other hand, maintained a soluble pool of Rnq1-
PFD. These data indicate that recruitment of Rnq1-PFD
monomers into aggregates occurs more readily for m.d. high
[RNQ+] in comparison to the s.d. [RNQ+] variants. Additionally, it
suggests that the Rnq1 N-terminus is important for facilitating
monomer addition and fiber growth with the s.d. [RNQ+] variants,
similar to what we demonstrated above for m.d. high [RNQ+]
using FL RRP.
Finally, we wanted to test whether this influence of the Rnq1 N-
terminal domain on fiber growth was necessary for propagation of
the [RNQ+] variants. To do this, we deleted RNQ1 in RRP-
expressing yeast cells that were complemented with a URA3-
marked plasmid expressing RNQ1. Cells that lose this plasmid
Chaperones and Amyloidogenicity of [RNQ+] Strains
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Figure 2. The non-prion forming domain of Rnq1 shows variant-specific influence on fiber growth. (A) Higher [RNQ+] variants confer
stronger [RRP+] phenotypes. Cells harboring RRP and the indicated [RNQ+] variant were normalized by OD600, serially diluted five-fold, and spotted
onto YPD, SD-ade, and YPD+3 mM GdnHCl (GdnHCl). Representative spottings are shown. (B) Mitotic stability of [RNQ+] variants. Averages indicate
the percentage of colonies that lost [RRP+] and error bars represent standard error of the mean calculated from at least three independent
experiments. (C) Expression of full-length (FL) RRP in m.d. high [RNQ+] cells is lethal. Normalized numbers of yeast cells propagating s.d. high [RNQ+],
m.d. high [RNQ+], or cured of m.d. high [RNQ+], and expressing Sup35, RRP, or FL RRP were serially diluted five-fold and spotted to select for loss (2
Sup35) or co-expression (+ Sup35) of wild-type Sup35. Representative spottings are shown. (D) Rnq1-PFD readily joins pre-existing Rnq1 aggregates
of m.d. high [RNQ+] as compared to s.d. [RNQ+] variants. Cells transformed with plasmids expressing HA-RNQ1 or RNQ1-PFD from the GAL1 promoter
were subcultured in galactose media. Lysates were incubated for five minutes at 100uC (+) or at room temperature (2), followed by SDS-PAGE and
western blot using an aRnq1 antibody. Data are representative of three independent experiments. (E) RRP is not sufficient to propagate m.d. high
[RNQ+] without expression of Rnq1. Normalized numbers of rnq1D cells harboring RRP were serially diluted five-fold and spotted to select for
Chaperones and Amyloidogenicity of [RNQ+] Strains
PLOS Genetics | www.plosgenetics.org 5 May 2014 | Volume 10 | Issue 5 | e1004337
would express only the Rnq1-PFD as part of RRP, and would not
express the Rnq1 N-terminal domain. After growing cultures in
non-selective media, we plated [rnq2] cells and cells propagating
each of the [RNQ+] variants on media to select for either
maintenance (SD-ura) or loss (5-FOA) of the RNQ1 plasmid. In
agreement with our previous results [49], m.d. high [RNQ+] did
not propagate when Rnq1 was lost, as it was phenotypically [rnq2]
on 5-FOA medium and did not grow on medium lacking adenine
and containing 5-FOA (Figure 2E). This suggests that the Rnq1-
PFD is not sufficient to propagate this variant. In stark contrast, all
of the s.d. [RNQ+] variants could still maintain [RNQ+], albeit to
varying degrees. This indicates that propagation of m.d. high
[RNQ+] has a greater reliance on the non-prion-forming N-
terminal domain than the s.d. [RNQ+] variants. Furthermore, it
suggests that propagation of the s.d. [RNQ+] variants might
differentially depend on the presence of the N-terminal domain.
Indeed, we passaged the rnq1D cells harboring the s.d. [RNQ+]
variants that had lost the RNQ1 plasmid and found that, after
further growth, these cells did not maintain the same [RRP+]
phenotype as the RNQ1 [RNQ+] cells expressing RRP (compare
Figure 2A to Figure 2F). For instance, both s.d. low and s.d.
medium [RNQ+] had a much stronger nonsense suppression
phenotype as compared to their phenotype when Rnq1 was
present.
Taken together, these data suggest that the [RNQ+] variants
show differences in fiber growth parameters, which are mediated,
in part, by the Rnq1 N-terminal domain. However, despite these
differences in properties of fiber growth and fragmentation, these
data do not wholly distinguish the [RNQ+] variants or explain their
differential ability to induce [PSI+]. This is in line with previous
work that also shows a lack of correlation [52]. Hence, these data
highlight the complex nature of both [PSI+] induction and the
phenotypic consequences that are possible with distinct aggregate
structures.
[RNQ+] variants show differential reliance on
amyloidogenic regions
To help elucidate the basis of the structural diversity of the
[RNQ+] variants and the phenotypic differences they modulate, we
postulated that each of the [RNQ+] variants, like [PSI+], has a
different part of the primary structure that is important for prion
propagation. Propagation of strong [PSI+] incorporates fewer
residues of the Sup35-PFD in the amyloid core as compared to
weak [PSI+], and this difference is tightly correlated to the
biochemical and phenotypic differences seen between [PSI+]
variants [21,22,28]. Hence, determining the regions of Rnq1 that
are important for propagation of each of the [RNQ+] variants
would provide insight into how the [RNQ+] variants are
structurally different and can mediate differences in [PSI+]
formation. To help identify these sequence elements, we used five
different algorithms that were developed to find regions of a
protein predicted to facilitate the formation of amyloid [64–68].
These algorithms found 11 putative amyloidogenic regions spread
throughout both the N-terminal domain and the PFD of Rnq1
(Figure 3). We will refer to these regions hereafter as A1 through
A11.
We set out to analyze the influence of these regions on the
propagation of the different [RNQ+] variants. We mutated each of
these regions in its entirety to alanine to make 11 Rnq1 mutant
constructs and confirmed expression levels similar to wild-type
(WT) Rnq1 (Figure S4). After using a plasmid shuffle technique to
replace WT Rnq1 with these mutants in cells propagating each of
the [RNQ+] variants, we then examined three biochemical
properties commonly used to monitor prion replication: 1) the
relative distribution of Rnq1 aggregates using SDD-AGE, 2) the
amount of soluble Rnq1 by solubility assay, and 3) the thermal
stability of Rnq1 aggregates. These assays provide complementary
information about the propagation of [RNQ+]; for example,
detection of monomeric Rnq1 with SDD-AGE is variable for
unknown reasons, thus using the solubility assay is informative.
Additionally, since these assays examine different aspects of prion
propagation, we hypothesized that we might see a difference by
one assay and not another. Therefore, collectively, these assays
allowed us to make conclusions about how mutation of the
amyloidogenic regions in Rnq1 affected [RNQ+] propagation.
For each assay, we categorized the reproducible effects of the
alanine mutants as mild, moderate, curing [RNQ+], or having no
effect (Figure S5). Taking all three assays into account, we then
scored the overall influence of disrupting the amyloidogenic
regions on each [RNQ+] variant (Figure 4A). As expected, since
our data above showed the involvement of the N-terminus in
[RNQ+] propagation, we found that the N-terminal alanine
mutants revealed regions of both common and unique importance
for the [RNQ+] variants. For instance, mutation of the A1 or A3
regions both affected the biochemical properties of all of the
[RNQ+] variants. However, these mutants also showed variant-
specific effects. With s.d. high [RNQ+], for example, expression of
the A1 and A3 mutants resulted in a dramatic shift in relative
aggregate size distribution, but the other N-terminal mutations
had minimal effect on propagation of s.d. high [RNQ+] (Figure 4B).
By contrast, the A3 mutant cured the m.d. high [RNQ+] variant,
while the A1 mutant resulted in a shift in aggregate size. These
data show that particular regions within the non-PFD N-domain
have differential roles on prion propagation depending on what
[RNQ+] variant is present. This indicates that this domain helps
define the physical basis of distinct [RNQ+] variants.
Prion-forming domains are historically considered the region
that forms the amyloid core of prion aggregates [50,69]. As such,
PFDs are predicted to encode variant-specific differences, as is the
case for weak and strong [PSI+] [21,22,28]. Indeed, we have
previously shown that deletion of part of the Rnq1-PFD
differentially affects the propagation of some [RNQ+] variants
[49]. Hence, we expected to uncover conformation-specific effects
with mutation of the amyloidogenic regions in the Rnq1-PFD. We
found that mutation of the A11 region affected propagation of all
of the [RNQ+] variants, but to varying degrees. For instance, the
A11 mutant was the only mutant that cured s.d. low [RNQ+]
(Figure 4C). On the other hand, none of the PFD alanine mutants
cured s.d. medium [RNQ+], only mutation of the N-terminal A3
region did (Figure 4D). This suggests that the A3 and A11 regions
are the most important of the amyloidogenic regions for
propagation of s.d. medium and s.d. low [RNQ+], respectively.
Strikingly, disruption of 8 of the 11 amyloidogenic regions affected
propagation of s.d. very high [RNQ+], with several alanine
mutants quickly curing this variant (A1, A5, A10, A11) (Figure 4E).
Additionally, upon further growth, the s.d. very high [RNQ+]
maintenance of Rnq1 expression (+ Rnq1), or loss of Rnq1 (2 Rnq1) on media to monitor color (5-FOA) and nonsense suppression (SD-ade+5-FOA)
phenotypes. Representative spottings are shown. (F) Loss of Rnq1 results in altered [RRP+] phenotypes. Normalized numbers of rnq1D cells harboring
RRP that lost Rnq1 expression, as shown in (E), were serially diluted five-fold and spotted onto YPD, SD-ade, and GdnHCl media to monitor the stable
[RRP+] phenotypes. Representative spottings are shown.
doi:10.1371/journal.pgen.1004337.g002
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variant was also cured by mutation of the A2, A3, A4, and A9
regions. Importantly, loss of [RNQ+] was confirmed by the absence
of SDS-resistant aggregates by SDD-AGE after re-transforming a
plasmid expressing WT Rnq1 and selecting for loss of the Rnq1
alanine mutant plasmid (Figure S6).
Overall, it has previously been shown that different, non-
adjacent Q/N-rich regions of the Rnq1 protein make differential
contributions to [RNQ+] propagation [70]. Our data now show
that a unique set of non-contiguous regions, even regions that are
not Q/N-rich, defines the propagation of the [RNQ+] variants.
This strongly supports the hypothesis that the [RNQ+] variants
propagate distinct structural conformations and likely mediate
differential induction of [PSI+] by exposing a different structural
template.
[RNQ+] variants have additional Sis1 binding sites
We wanted to better understand the role that these putative
amyloidogenic regions play in propagating the different confor-
mations of [RNQ+]. We noted that most of these regions were
primarily hydrophobic, with some regions being previously
identified as separating the Q/N-rich regions of the Rnq1-PFD
[70]. It was unsurprising that the prediction algorithms identified
these regions, as hydrophobic residues are generally recognized as
sites that facilitate protein interactions, whether normal or
abnormal interactions [71]. We conjectured two predominant
ways that mutation of these amyloidogenic regions could affect the
prion replication cycle of [RNQ+]: 1) disrupting the aggregate
structure, or 2) disrupting the ability of chaperones to bind the
Rnq1 aggregates. Interestingly, one of the amyloidogenic regions
of Rnq1, A3 (aa 92-102), was previously identified as containing a
binding site for the Hsp40 chaperone Sis1 [72]. Disruption of this
site using the Rnq1-L94A mutation impairs Sis1 binding and
eliminates the [RNQ+] prion [72,73]. Moreover, the bacterial
Hsp40 has been predicted to bind several different hydrophobic
stretches in each protein of nearly the whole proteome [74,75]. In
line with this, we found that the ANCHOR algorithm, which
predicts protein-binding sites in disordered stretches [76,77],
identified all of our amyloidogenic regions (except the lone
hydrophilic A9 region) to be putative chaperone-binding sites
(Figure 5A). As such, we first wanted to test whether Sis1 could
bind other regions of Rnq1 outside of the known A3 binding site.
To do this, we expressed Rnq1-PFD (which lacks the A3 binding
site) in place of full-length Rnq1 in cells propagating each of the
[RNQ+] variants. Upon immunoprecipitating Sis1, we found that
Sis1 could still bind the PFD of Rnq1 in [RNQ+] cells, but not in
[rnq2] cells (Figure 5B), suggesting that some of the amyloidogenic
Figure 3. Consensus amyloidogenic regions of Rnq1 identified by prediction algorithms. (A) Diagram of the Rnq1 protein highlighting
the N-terminal domain (N) between residues 1-152, the putative prion-forming domain (PFD) between 153-405, and the identified amyloidogenic
regions. (B) Residues and sequences of the predicted amyloidogenic regions and which algorithm identified that region: 1) Zyggregator (http://www-
vendruscolo.ch.cam.ac.uk/zyggregator.php); 2) PASTA (http://biocomp.bio.unipd.it/pasta/); 3) TANGO (http://tango.crg.es/); 4) Aggrescan (http://
bioinf.uab.es/aggrescan/); 5) WALTZ (http://waltz.switchlab.org/).
doi:10.1371/journal.pgen.1004337.g003
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Figure 4. Distinct regions of Rnq1 are important for each [RNQ+] variant. (A) Summary of how disruption of the amyloidogenic regions by
alanine mutations affects propagation of the [RNQ+] variants. Mutants are categorized as having no effect (white), mild effect (yellow), moderate
effect (orange), or not propagating [RNQ+] (red) after successive passaging. These effects on [RNQ+] propagation were summarized from at least
three independent experiments of each of the following assays: solubility assay, thermal stability, and SDD-AGE. See Figure S5 for more detail. If only
one assay showed mild effects, e.g. SDD-AGE of s.d. low [RNQ+] cells harboring the A6 mutant, this was scored as having no effect in this summary
table. (B) Mutation of the Rnq1 N-terminal domain shows [RNQ+] variant-dependent effects. Lysates from cells propagating s.d. high or m.d. high
[RNQ+] and expressing wild-type (WT) Rnq1 or the N-terminal alanine mutants (A1–A5) were resolved by SDD-AGE, followed by western blot using an
aRnq1 antibody. (C–E) Mutation of Rnq1 amyloidogenic regions differentially affects [RNQ+] variants. Yeast lysates propagating (C) s.d. low [RNQ+],
(D) s.d. medium [RNQ+], or (E) s.d. very high [RNQ+] expressing WT Rnq1 or the set of alanine mutants (A1–A11) were analyzed by SDD-AGE and
western blot with an aRnq1 antibody.
doi:10.1371/journal.pgen.1004337.g004
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regions in the Rnq1-PFD may serve as additional binding sites for
Sis1. Interestingly, in contrast to Figure 1D in which Sis1 bound
equal levels of full-length Rnq1 in all of the [RNQ+] variants, there
was distinctly less Rnq1-PFD bound to Sis1 in the m.d. high
[RNQ+] variant. While we confirmed that these cells were still
[RNQ+] at this time point (data not shown), this suggests that
propagation of the m.d. high [RNQ+] conformer might uniquely
require the presence of the A3 binding site. Indeed, this would
provide some mechanistic explanation for our finding that the
Rnq1-PFD as part of RRP is not sufficient for propagation of the
m.d. high [RNQ+] variant in particular (Figure 2E).
Rnq1 amyloidogenic regions differentially contribute to
the interaction of Sis1 with the [RNQ+] variants
Since Sis1 only binds Rnq1 in [RNQ+] cells, it is challenging to
distinguish whether loss of Sis1 binding results in curing [RNQ+],
or if curing [RNQ+] by disrupting some other aspect required for
prion propagation results in loss of Sis1 binding. As the A3 region
was previously shown to be a major binding site for Sis1, we
hypothesized that disruption of this region by the Rnq1-L94A
mutation would provide a useful comparison for examining how
mutation of the amyloidogenic regions influences Sis1 binding and
propagation of [RNQ+]. Therefore, to determine the effect of
Figure 5. Rnq1 amyloidogenic regions differentially modulate interactions with Sis1. (A) Prediction of protein interaction sites in Rnq1
using the ANCHOR algorithm (http://anchor.enzim.hu/). Denoted at the top are the amyloidogenic regions A1–A11. (B) Co-immunoprecipitation of
Sis1 and Rnq1(132-405). Sis1 was immunoprecipitated using an aSis1 antibody (gift from E. Craig) from cell lysates expressing Rnq1(132-405) in place
of WT Rnq1, followed by SDS-PAGE and immunoblotting with aRnq1 and aSis1 antibodies. The input of the total cell lysate (I) represents 10% of the
sample that was bound by the aSis1 antibody (B). The bound fraction from the same sample not incubated with antibody (N) was used as a control.
(C) Rnq1-L94A differentially affects [RNQ+] variant propagation and is rescued by Sis1 over-expression. Cell lysates with (+) or without (2) over-
expression (OE) of Sis1 and propagating the indicated [RNQ+] variant with WT Rnq1 or Rnq1-L94A were subjected to SDD-AGE and western blot using
an aRnq1 antibody. (D–F) Elimination of [RNQ+] by mutation of Rnq1 amyloidogenic regions is differentially rescued by Sis1 over-expression. As in (C)
for (D) cells propagating s.d. medium [RNQ+] or m.d. high [RNQ+] and expressing WT Rnq1 or the A3 mutant, or (E) cells propagating s.d. very high
[RNQ+] expressing WT Rnq1 or mutants A1–A5 or A9–A11. (F) Yeast lysates propagating s.d. very high [RNQ+], over-expressing Sis1, and expressing
WT Rnq1, or mutants A1–A5 or A9–A11 were incubated for five minutes at 100uC (+) or at room temperature (2), followed by SDS-PAGE and western
blot using an aRnq1 antibody. Data are representative of at least three independent experiments.
doi:10.1371/journal.pgen.1004337.g005
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Rnq1-L94A on [RNQ+] propagation, we expressed Rnq1-L94A in
place of WT Rnq1 in cells propagating each of the [RNQ+]
variants and monitored the maintenance of [RNQ+] by SDD-
AGE. Like the variant-specific differences we observed above, we
found that Rnq1-L94A also differentially affected the [RNQ+]
variants: s.d. very high [RNQ+] could still propagate while the
other four [RNQ+] variants were cured (Figure 5C). However,
upon growing cells additional generations, we found that s.d. very
high [RNQ+] was eventually cured as well (data not shown). This
delayed curing suggests that s.d. very high [RNQ+] does not rely on
the L94 Sis1 binding site in the A3 region to the same extent as the
other [RNQ+] variants. Importantly, over-expressing Sis1 before
replacing WT Rnq1 with Rnq1-L94A rescued propagation of the
[RNQ+] variants, as an SDS-resistant species was still maintained
(Figure 5C) and was transmissible (data not shown). Therefore,
these data indicate that over-expression of Sis1 compensates for
the disruption of Sis1 binding caused by the Rnq1-L94A mutation.
In using Rnq1-L94A as a model of how disruption of Sis1
binding affects [RNQ+], we hypothesized that if mutation of the
Rnq1 amyloidogenic regions impaired the binding of Sis1, then
Sis1 over-expression would at least partially rescue the propaga-
tion of the [RNQ+] variants. As a corollary, we postulated that if
the mutations instead disrupted the Rnq1 aggregate structure,
then these mutants would still cure [RNQ+] despite Sis1 being
over-expressed. Therefore, as we did using Rnq1-L94A, we over-
expressed Sis1 before replacing WT Rnq1 with the alanine
mutants and tested whether propagation of the [RNQ+] variants
was rescued using SDD-AGE to monitor the presence of SDS-
resistant aggregates. As expected from our data with Rnq1-L94A,
Sis1 over-expression rescued the propagation of m.d. high [RNQ+]
and s.d. medium [RNQ+] that were both cured by mutation of the
A3 region, which encompasses L94 (Figure 5D).
Propagation of s.d. very high [RNQ+], on the other hand, was
impaired by mutation of several different amyloidogenic regions
(Figure 4). This allowed us to gain a more complete picture of how
multiple regions of Rnq1 influence propagation of this prion
variant. Strikingly, Sis1 over-expression differentially rescued
propagation with these mutants, even when comparing N-terminal
and C-terminal mutants (Figure 5E). Sis1 over-expression did not
rescue s.d. very high [RNQ+] propagation when the A4, A5, or
A11 regions were mutated to alanine. This suggests that these
regions likely disrupt the aggregate structure of s.d. very high
[RNQ+], thereby impairing the recruitment and conversion of
monomeric Rnq1. By contrast, Sis1 over-expression did rescue the
propagation of s.d. very high [RNQ+] when the N-terminal A1,
A2, and A3 regions were mutated, along with the C-terminal A9
and A10 regions. Thus, these data support our hypothesis that
mutation of these regions impairs Sis1 binding, which is overcome
by Sis1 over-expression.
In order to more finely monitor the degree to which Sis1 over-
expression rescued propagation of s.d. very high [RNQ+], we
determined the amount of soluble Rnq1 using a well-trap assay. As
SDD-AGE does not allow us to consistently visualize monomeric
Rnq1, the well-trap assay provided a more sensitive measure of
soluble Rnq1, and hence, of how much of the Rnq1 protein is not
incorporated into aggregates. In agreement with our results using
SDD-AGE, we found that in cells originally propagating the s.d.
very high [RNQ+] variant, all of the Rnq1 protein of the A4, A5,
and A11 mutants was in soluble form when Sis1 was over-
expressed, and could enter the SDS-PAGE gel in the fraction that
was not boiled (Figure 5F). At the other end of this spectrum, all of
the Rnq1 protein was in its aggregated form with the A3 and A10
mutants, thus phenocopying WT Rnq1. Mutation of the A1, A2,
and A9 regions, on the other hand, resulted in an intermediate
amount of soluble Rnq1 when Sis1 was over-expressed. These
data show that Sis1 over-expression rescues propagation of s.d.
very high [RNQ+] to widely varying degrees when the different
amyloidogenic regions are mutated. We hypothesize that mutation
of the A1, A2, and A9 regions likely allosterically impact Sis1
binding, and so are only partially rescued by Sis1 over-expression.
The A3 and A10 regions, on the other hand, may represent direct
binding sites for Sis1 in the context of the s.d. very high [RNQ+]
conformation. In fact, the peptide-binding array that discovered
the affinity of Sis1 for the L94 region (A3) of Rnq1 also showed
some affinity, albeit weaker, for the A10 region [72]. This further
supports our hypothesis that the [RNQ+] variants expose different
parts of the Rnq1 protein to interact with Sis1.
[RNQ+] variant conformation dictates dependence on
Sis1 binding sites
The data above suggest that propagation of the s.d. very high
[RNQ+] variant likely relies on Sis1 binding to both the A3 and
A10 regions. The other [RNQ+] variants, however, clearly show a
difference in the importance of these regions for prion replication.
Both the s.d. medium and m.d. high [RNQ+] variants were cured
when the A3 region was mutated, but these conformations could
still propagate with the A10 mutant (Figure 4). By contrast,
mutation of neither of these regions eliminated the aggregates of
s.d. low or s.d. high [RNQ+]. As such, we hypothesized that the A3
and A10 regions might have some redundancy with these [RNQ+]
variants, whereby the A10 region serves as another Sis1 binding
site, as our data suggest for s.d. very high [RNQ+], albeit to a lesser
degree. To test this, we created the double mutant of Rnq1 having
both the A3 and A10 regions mutated to alanine, termed Rnq1-
A3+A10. We then replaced WT Rnq1 and confirmed similar
expression (Figure S4). Upon continual growth, we monitored how
quickly [RNQ+] was cured using SDD-AGE. Interestingly,
mutation of both regions cured s.d. low and s.d. high [RNQ+],
but at different rates: s.d. high [RNQ+] was cured much faster than
s.d. low [RNQ+] (Figure 6). Furthermore, the double mutant cured
both s.d. medium and m.d. high [RNQ+] faster than either single
mutant (data not shown). These results indicate that both putative
Sis1 binding sites in the A3 and A10 regions influence propagation
of the [RNQ+] variants, but the extent to which these regions are
utilized is variant-specific.
Rnq1 amyloidogenic regions have [RNQ+] variant-
dependent effects on [PSI+] formation
By identifying the Rnq1 amyloidogenic regions as major factors
in distinguishing the ability of the [RNQ+] variants to propagate,
we next wanted to determine whether these differences had any
functional consequence on the differential ability of the [RNQ+]
variants to induce [PSI+]. We envisioned two ways that these
regions could affect the formation of [PSI+] in a variant-specific
manner: 1) through mediating the differential binding of Sis1,
where Sis1 plays a role in facilitating interaction with Sup35, and
2) having a different set of Rnq1 residues that facilitate the
interaction with Sup35 through cross-seeding.
To test the first possibility, we asked whether over-expression of
Sis1 would enhance the rate of spontaneous [PSI+] formation, as it
has been shown to do for [URE3] [78]. The spontaneous
conversion to [PSI+] is normally a rare event, occurring at a rate
of ,5.861027 [79]. We transformed [rnq2] [psi2] cells or [psi2]
cells propagating m.d. high, s.d. high, or s.d. very high [RNQ+]
with a plasmid that over-expressed Sis1 or an empty vector
control. We then selected for nonsense suppressors and screened
for cells that had spontaneously converted to [PSI+]. We found
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that Sis1 over-expression significantly increased the level of
spontaneous [PSI+] formation in [RNQ+] cells, but not in [rnq2]
cells (Figure 7A). The apparent increase in [PSI+] formation was
not due to any noticeable difference in the distribution of [PSI+]
variants obtained (data not shown). Moreover, there were no
significant differences in the levels of Hsp104 or Ssa, both of which
are known to modulate the existence of [PSI+] (Figure S7) [80,81].
This indicates that Sis1 helps facilitate the formation of [PSI+],
thereby suggesting that the differential interaction between Sis1
and the [RNQ+] variants might contribute to their different
capabilities of cross-seeding Sup35.
Next, we wanted to determine if the [RNQ+] variants might
have different regions of Rnq1 involved in facilitating [PSI+]
formation. Previously, we have shown that some mutations in
Rnq1 that have no detectable effect on the Rnq1 aggregate
structure can decrease the ability of [RNQ+] to induce [PSI+] [49].
This suggested that these residues are involved in facilitating the
interaction and cross-seeding of Sup35 to form [PSI+]. Thus, we
asked whether disruption of the Rnq1 amyloidogenic regions
would show variant-specific effects on [PSI+] induction. In cells
propagating each of the [RNQ+] variants and harboring the Rnq1
alanine mutants in place of WT Rnq1, we over-expressed Sup35,
which greatly enhances the de novo formation of [PSI+]. We then
analyzed [PSI+] formation by monitoring growth on media lacking
adenine. Strikingly, we found that disruption of the Rnq1
amyloidogenic regions had a variety of effects on [PSI+] induction
(Figures 7B–E and S8). As we expected, we found that some
mutations that affected [RNQ+] also affected the formation of
[PSI+]. For instance, mutation of the N-terminal A1 region
affected propagation of all of the [RNQ+] variants. While we
anticipated that this destabilization would cause decreased
formation of [PSI+], it actually enhanced [PSI+] formation for
the s.d. low, s.d. medium, and m.d. high [RNQ+] variants, as we
saw an increase in Ade+ colonies (Figure 7B). By contrast,
mutation of the A7 region had very little effect on propagation of
any of the [RNQ+] variants, but it enhanced [PSI+] induction in
most of them (Figure 7C). This suggests that this region might have
general importance in facilitating the interaction with Sup35.
Moreover, disruption of the A9 region showed quite varied effects,
greatly decreasing [PSI+] formation with s.d. high [RNQ+], but
increasing it with s.d. low and m.d. high [RNQ+] (Figure 7D),
despite not grossly affecting the overall structures of these three
[RNQ+] variants (Figure 4A). Overall, these variant-specific effects
indicate that the [RNQ+] variants have different regions of the
Rnq1 protein that are important for [PSI+] induction (Figure 7E).
Moreover, these regions are not confined to the Rnq1-PFD.
Discussion
It has previously been shown that a single amyloidogenic
protein, Rnq1, can form a wide variety of different prion variants,
many of which differentially influence the formation of [PSI+]
[33,44]. Similarly, it is estimated that PrPSc likely exists in over 30
different prion strains [11]. However, the physical and mechanistic
basis underlying different prion strains and their associated
phenotypes has only been elucidated using two variants of the
[PSI+] prion. Our work reveals additional layers of complexity that
help explain the widespread diversity of amyloid polymorphism
and phenotypic variation. Here, we show in vivo that different
amyloidogenic regions, both within and outside of the putative
PFD, as well as different interactions with cofactors, are key
determinants in distinguishing, and likely generating, distinct prion
variants. This provides significant insight into how certain prion
strains can be biochemically indistinguishable, but confer different
pathological consequences [82].
Previous work has emphasized the importance of fiber stability
in distinguishing prion variants [19,20,31,32,34]. The less stable
Sup35 fibers of strong [PSI+] cause increased fragmentation into a
greater number of smaller prion seeds that recruit more Sup35
monomer [20]. Similarly, less stable prion strains of PrPSc
correlated with shorter incubation periods [31,32]. In this study,
we show a similar trend with the m.d. high [RNQ+] variant. This
[RNQ+] variant propagated less stable Rnq1 aggregates as
compared to the s.d. [RNQ+] variants (Figure 1A). This correlated
with several properties that show that m.d. high [RNQ+] cells
readily sequester Rnq1 monomer: solubility [44], mitotic stability,
[RRP+] phenotype, and inviability with FL RRP (Figure 2).
Hence, we propose that the decreased stability of m.d. high [RNQ+
], like strong [PSI+], results in an increased number of propagons,
as previously reported [52], which then enhances the ability of
Rnq1 monomer to join pre-existing aggregates.
However, the decreased fiber stability does not explain all the
properties of m.d. high [RNQ+], nor all the differences between the
[RNQ+] variants. Despite the lower stability, which is predicted to
increase fiber fragmentation into smaller aggregates, m.d. high
[RNQ+] propagated aggregates of a larger average size than other
[RNQ+] variants (Figure 1C). Also, both s.d. high and s.d. very
high [RNQ+] were more thermal stable, which is predicted to
cause less nonsense suppression, but these variants caused a
similarly strong nonsense suppression phenotype as compared to
m.d. high [RNQ+] (Figures 1 and 2). Therefore, our data suggest
that thermal stability, while a crucial parameter, does not serve as
a perfect measure of fiber fragmentation, and cannot explain the
Figure 6. [RNQ+] variants rely on putative Sis1 binding sites to
different extents. Propagation of s.d. high [RNQ+] is eliminated faster
than s.d. low [RNQ+] when Rnq1-A3+A10 is expressed. Yeast cells
propagating the indicated [RNQ+] variant and expressing either WT
Rnq1 or Rnq1-A3+A10 were successively passaged three or six times
after plasmid shuffle. Cell lysates were subjected to SDD-AGE and
western blot using an aRnq1 antibody, and are representative of three
independent experiments.
doi:10.1371/journal.pgen.1004337.g006
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Figure 7. Sis1 over-expression and Rnq1 amyloidogenic regions influence the formation of [PSI+]. (A) Over-expression of Sis1 enhances
the spontaneous formation of [PSI+] in [RNQ+] cells. [rnq2] [psi2] and [RNQ+] [psi2] cells were transformed with a Sis1 over-expressing plasmid (Sis1
OE) or an empty vector control (EV). Cultures were plated on medium that selected for [PSI+] cells as well as a non-selective medium to determine the
total number of cells plated. Averages and error bars representing standard error of the mean were calculated from at least three independent
experiments. Statistical significance was assessed using Student’s t-test (*p,0.05, **p,0.01). (B–E) Cells expressing WT Rnq1 or the indicated mutant
Rnq1 were transformed with a plasmid to over-express Sup35. [PSI+] induction was monitored by spotting five-fold serial dilutions of normalized cell
numbers on SD-ade and SD-ade-his. Representative spottings are shown of cells expressing the mutants (B) A1, (C) A7, or (D) A9 in comparison to
expression of WT Rnq1. (E) Summary of data showing how disruption of the amyloidogenic regions by alanine mutations affects [PSI+] induction in
each of the [RNQ+] variants. Mutants were categorized as having no effect (white), ,5-fold increase (green) or decrease (orange) in [PSI+] induction,
or .5-fold increase (blue) or decrease (red) in [PSI+] induction. Black boxes indicate that [RNQ+] was eliminated, while black hash marks indicate that
[RNQ+] propagation was altered (see Figure 4). Data are summarized from at least five independent experiments.
doi:10.1371/journal.pgen.1004337.g007
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existence of many different aggregate structures, nor the large
variability in phenotype. Moreover, our work and that of another
group show that many additional properties that helped elucidate
the physical basis of [PSI+] variants, similarly do not distinguish
the [RNQ+] variants and their phenotypic effects on [PSI+]
[33,44,51,52]. These data indicate that additional factors influence
prion strain propagation and the resulting phenotypes, and
highlight the wide variety of polymorphic structures that can exist
[7], with [PSI+] and [RNQ+] variants possibly exhibiting different
types of polymorphism (e.g. packing versus segmental).
Several studies have examined the primary structural elements
that are important for prion propagation, with particular emphasis
on the prion-forming domains. A different length of the same
stretch of contiguous residues of Sup35 was found to be protected
in the amyloid structure of different [PSI+] variants [21]. Other
work has shown that prion transmission involves the differential
contribution and cooperation of discontinuous intragenic regions
of the Rnq1-PFD [70]. Our data extend these findings, as we
showed that disruption of certain discontinuous amyloidogenic
regions in the Rnq1-PFD show variant-specific effects on [RNQ+]
propagation (Figures 4 and S5). For instance, mutation of the A11
region, despite impairing propagation of all the [RNQ+] variants
we analyzed, did so to varying degrees. Also, mutation of the A9
region eliminated s.d. very high [RNQ+] and affected propagation
of s.d. medium [RNQ+], but had no noticeable impact on the other
[RNQ+] variants, in agreement with some of our previous work
[49]. Importantly, there were no reproducibly significant differ-
ences in protein expression of the alanine mutants that could
explain their differential effects (Figure S4). Hence, these data
clearly establish that the involvement and cooperation of non-
adjacent regions of the PFD can vary with the type of prion variant
that propagates.
In addition to the Rnq1-PFD, we found that the often-
overlooked N-terminal non-Q/N-rich domain of Rnq1 has a
prion variant-dependent influence on prion propagation (Figures 2
and 4). Sequences flanking the aggregation-prone part of proteins,
even between regions that are far apart in the primary structure,
have previously been implicated in influencing aggregation
dynamics [60,83–89]. For instance, amyloid fibers formed with
Sup35NM as compared to those formed with full-length Sup35
have morphologically and biochemically distinct properties [90–
92]. Similarly, it was recently shown that the region outside of the
amyloid core has different structural dynamics for different [PSI+]
variants [93]. Two models have been proposed to explain how
regions outside the PFDs may be involved in amyloid assembly
and propagation: 1) serving to dock monomers, with the PFD
forming the amyloid core and the non-PFD outside, or 2)
incorporating within the core of the fiber assembly itself [60].
Our data strongly suggest that the non-PFD domain of Rnq1 helps
facilitate monomer addition into aggregates (Figure 2). However,
we also show that mutation of N-terminal amyloidogenic regions
differentially disrupted propagation of the [RNQ+] variants
(Figure 4). Hence, we propose that both of these models could
be correct, depending on what prion variant is propagating. In
fact, as our work indicates that regions outside the unstructured
Q/N-rich domains can have a major influence on propagation of
particular prion variants, our data may help explain particular
inconsistencies when using the full-length protein or truncated
derivatives to examine the in vivo and in vitro properties of prion
variants [52,58].
Along with the influence on prion propagation, we also show
that different primary structural elements likely dictate different
phenotypic and pathological ramifications of prion strains. We
found that mutation of certain amyloidogenic regions of Rnq1
causes variant-dependent alterations in the interaction with
Sup35, thereby altering the degree of [PSI+] formation (Figures 7
and S8). In several cases, there was minimal to no detectable effect
on maintenance of Rnq1 aggregates. Hence, while it is proposed
that amino acid composition, rather than the exact sequence, is
the primary driver of amyloid maintenance [94,95], our data
suggest that even relatively subtle variation in primary sequence
can have profound effects on some properties of prion variants, but
not others. Therefore, we have now established that the
contribution of different regions of an amyloidogenic protein can
help account for the biological differences seen between prion
strains, such as the variation in [PSI+] formation mediated by the
[RNQ+] variants.
We also discovered a striking difference in the relationship of the
[RNQ+] variants with Sis1. Mutation of the A10 region in the
Rnq1-PFD eliminated the ability of only the s.d. very high [RNQ+]
variant to propagate (Figure 4), but this was rescued by over-
expression of Sis1 (Figure 5), suggesting that the A10 region might
be a secondary Sis1 binding site, in agreement with a previous
peptide-binding array [72]. Interestingly, s.d. very high [RNQ+]
was also the least affected by mutation of the known Sis1 binding
site in the A3 region (using the Rnq1-L94A mutant). At the other
end of this spectrum, s.d. medium [RNQ+] and m.d. high [RNQ+]
were most sensitive to disruption of the A3 region, but there was
no detectable effect when the A10 region was mutated. In stark
contrast, for s.d. low and s.d. high [RNQ+], it was only when both
the A3 and A10 regions were mutated that these prion variants
were eliminated, with propagation of s.d. high [RNQ+] being
abolished faster than s.d. low [RNQ+] (Figure 6). Surprisingly,
disruption of the known Sis1 binding site using the A3 mutant did
not entirely phenocopy the effects of Rnq1-L94A. We hypothesize
that this might be attributed, at least in part, to higher steady state
levels of Rnq1-L94A (Figure S4), and possibly in addition, how the
residues surrounding L94 that are mutated in the A3 mutant are
involved in propagation of particular [RNQ+] variants. Collec-
tively, while we cannot definitively exclude the possibility that the
Rnq1 alanine mutants are affecting multiple factors important for
prion propagation, our data strongly support the hypothesis that
propagation of the [RNQ+] variants relies on Sis1 differentially
binding various sites exposed by the distinct Rnq1 aggregate
structures. As we demonstrated that the over-expression of Sis1
can enhance the formation of [PSI+] in [RNQ+] cells (Figure 7A),
we propose that such differential binding may influence the
phenotypic impact of the [RNQ+] variants on [PSI+] inducibility.
It is suggested that similar chaperone dynamics might also
influence the physical basis of [PSI+] variants. As Hsp104 can bind
Sup35 in [PSI+] cells [53] and is required for propagation of the
[PSI+] prion [80], one would predict that abrogation of the
Hsp104 binding site in Sup35 would eliminate the ability of [PSI+]
to propagate. However, propagation of a strong [PSI+] variant was
maintained, albeit impaired, when Hsp104 binding was disrupted
using sup35D129-148 [96]. This suggests that Hsp104 must be able
to bind other sites in Sup35. Moreover, recent work shows that this
binding site can adopt different conformations for different [PSI+]
variants, which might influence Hsp104 binding [93]. In fact,
particular [PSI+] variants have been isolated that require increased
levels of Hsp104 to stably propagate [97,98]. Our work now
provides a mechanistic explanation of these previous findings,
supporting the hypothesis that different chaperone dependencies
may be dictated by the exposure or conformation of different
regions of the protein [99]. Indeed, these different amyloid-
chaperone relationships likely explain why differences in the host
environment, due to different genetic backgrounds or environ-
mental conditions, can modulate prion propagation [100,101].
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Moreover, our data support the hypothesis that different host
cofactors might interact with different amyloid structures to
influence pathology [102].
With such a large variety of distinct structures that can be
adopted with the same protein [6,7,11,103], it was unclear how
general the model that elegantly explains the physical basis of
[PSI+] variants might be. We found that the parameters that
define this model do not distinguish a set of [RNQ+] variants or
explain their phenotypic effects. Our work now shows that
disparate, non-adjacent amyloidogenic regions and complex
interactions with chaperones contribute to defining the propaga-
tion of distinct prion variants. These data help elucidate what
factors are involved in determining a wide array of structural
differences and their associated phenotypic consequences. This
may provide insight as to why some prion strains are indistin-
guishable based on typical biochemical properties, but have very
different pathological phenotypes [82]. Furthermore, our study
highlights the intricate interplay between several factors, including
cofactor-amyloid interactions, which likely underlie the ability of
distinct amyloid structures to co-aggregate with different proteins
and cause variation in disease pathology.
Materials and Methods
Yeast strains and media
All yeast strains used in this study were derivatives of 74-D694
(ade1-14 ura3-52 leu2-3,112 trp1-289 his3-D200) and are described
in Table S1. Yeast were grown and manipulated using standard
techniques. As indicated, cells were grown in YPD (1% yeast
extract, 2% peptone, 2% dextrose) or synthetic media (0.67%
yeast nitrogen base without amino acids, 2% dextrose or 2%
galactose+1% raffinose) lacking one or more nutrients (e.g. SD-his
lacks histidine) to select for appropriate plasmids. YPD+3 mM
guanidine hydrochloride (GdnHCl) was used to test prion
curability. The plasmid shuffle technique was used by plating
cells on media containing 1 mg/mL 5-fluoroorotic acid (5-FOA)
to counterselect against cells that maintained URA3-containing
plasmids. Reverse plasmid shuffle of WT Rnq1 was performed by
transforming these Ura2 cells with a URA3 plasmid, and
screening for Ura+ His- cells.
Wild-type [rnq2] and [RNQ+] yeast strains (L1751, L1943,
L1945, L1767 [psi2], L1953, L1749) were a kind gift from Dr.
Susan Liebman [44,51]. Derivatives of these strains expressing
RRP were constructed as described previously using pRS306-RRP
[49]. Integration of RRP in the SUP35 locus was confirmed by
PCR and western blot. The rnq1D::kanMX4 strains were made as
described previously [49]. The sup35D::hphMX4 strains were made
by first passaging Mat a and Mat a 74-D694 [PSI+] [RNQ+]
sup35D::hphMX4 strains on YPD+3 mM GdnHCl. These were
confirmed to be [psi2] by maintaining a red color when streaked
back to YPD, and also confirmed to be [rnq2] by well-trap assay.
These strains were then mated to RNQ1 plasmid shuffle strains
containing pRS313-RNQ1 and propagating one of the [RNQ+]
prion variants. Diploids were sporulated and colonies that were
HygBR, Ura+, 5-FOAs, G418s, and His- were selected. The
[RNQ+] variant was confirmed by well-trap assay and [PSI+]
induction.
Plasmid construction
All plasmids used in this study were confirmed by sequencing
and are listed in Table S2, and all oligonucleotides are listed in
Table S3. Construction of pRS306-RRP, pRS313-RNQ1, pRS316-
RNQ1, pRS413GPD-L94A, and pEMBL-SUP35 were described
previously [33,49,73]. The following plasmids were gifts:
pRS414GPD-SIS1 (S. Lindquist [54]), pYK810 (M. Tuite [104]),
and pYES2-GAL-HA-RNQ1 (E. Craig [55]). Galactose-inducible
RNQ1(153-405) was made by amplification using oligonucleotides
1626 and 0040, digestion with HindIII/XhoI, and ligation into
pYES2-GAL-HA-RNQ1.
To create pRS315-SUP35 and pRS315-RRP, the SUP35
promoter was first amplified using oligonucleotides 1367 and
0316. This product and pRS315 were digested with SalI/BamHI
and ligated to make pRS315-SUP35p. The SUP35 open-reading
frame and terminator were then amplified using oligonucleotides
1348 and 0322, digested with BamHI/XbaI, and ligated into
pRS315-SUP35p. A BamHI/SacI fragment of RRP was digested
from pRS316-RRP that was previously described [49] and ligated
into pRS315-SUP35p. To make pRS315-full-length-RRP, full-
length RNQ1 was amplified using oligonucleotides 0477 and 0320,
digested with BamHI/SacII and ligated with pRS316-RRP. Full-
length RRP with the SUP35 promoter and terminator were then
amplified using oligonucleotides 1366 and 0322, digested with
XhoI/SacI, and ligated into pRS315.
All RNQ1 alanine mutants were cloned using bridge PCR. The
N-terminus of RNQ1 was amplified using oligonucleotide 0488 and
the oligonucleotide containing the corresponding rnq1 mutant.
The C-terminus of RNQ1 was amplified using the reverse
complement of the mutant-specific oligonucleotide with 0489.
The two amplicons were then used as a template to amplify the
full-length rnq1mutant using oligonucleotides 0488 and 0489. This
product was digested with EcoRV/SalI and ligated into the
previously described pRS313 plasmid containing the RNQ1
promoter and terminator [49], thereby expressing the Rnq1
mutants at protein levels close to WT (Figure S4). As an exception,
rnq1-A11 and the RNQ1 terminator were amplified using
oligonucleotide 0491 in place of 0489 and digested with
EcoRV/XhoI. The N-terminus of rnq1-A3+A10 was amplified
using oligonucleotides 0488 and 0018 with pRS413TPI1-rnq1-A3
as the template, while the C-terminus was amplified using
oligonucleotides 0014 and 0489 with pRS313-rnq1-A10 as the
template. Similar to what we previously saw with Rnq1-L94A
[73], the rnq1 mutants A1, A3, and A3+A10 were cloned into
pRS413TPI1 as these mutants had lower steady state protein levels
as compared to WT Rnq1 when expressed from the endogenous
RNQ1 promoter. Expression from the TPI1 promoter resulted in
slightly higher protein levels for Rnq1-A1 as compared to WT
Rnq1, but WT protein levels for Rnq1-A3 and Rnq1-A3+A10
(Figure S4). Furthermore, the A1, A2, and A11 mutants
consistently ran higher than WT Rnq1 by SDS-PAGE despite
having the same number of amino acids. To make pRS413TPI1,
the TPI1 promoter was amplified using oligonucleotides 1429 and
1430, digested with SacI/XbaI, and ligated into pRS413ADH cut
with the same enzymes to replace the ADH1 promoter. Finally,
pRS413TEF-RNQ1(132-405) was cloned with oligonucleotides
1436 and 0489 and digested with EcoRV/SalI.
Protein analysis
Sedimentation of Rnq1 by solubility assay and SDD-AGE were
performed using established methods [33,49]. For well-trap and
thermal stability assays, yeast cell lysates were prepared by
vortexing with glass beads in buffer (100 mM Tris pH 7.5,
200 mM NaCl, 1 mM EDTA, 5% glycerol, 0.5 mM DTT, 3 mM
PMSF, 50 mM N-Ethylmaleimide (NEM), complete protease
inhibitor from Roche). Lysates were pre-cleared by centrifugation
at 3,300g for 15 sec. For well-trap assays, protein concentration
was normalized, and samples were treated in sample buffer
(50 mM Tris-HCl pH 6.8, 10% glycerol, 2% SDS, 100 mM
DTT) for 5 minutes at room temperature or 100uC. For thermal
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stability assays, samples were also incubated at a temperature
gradient (45uC to 95uC) for 5 minutes. Samples were then
analyzed by SDS-PAGE and western blot using a polyclonal
aRnq1 antibody.
Limited proteolysis
[RNQ+] cell lysates were prepared as above for well-trap assays,
with the exception of adding PMSF to the buffer. Protein
concentration was normalized to ,3 mg/ml, followed by addition
of proteinase K (Sigma-Aldrich) to varying concentrations.
Samples were incubated at 37uC in a water bath for 30 min or
1 hr as indicated. The reaction was stopped by adding sample
buffer and boiling samples at 100uC for 5 min, followed by SDS-
PAGE and western blot using an aRnq1 antibody. Cell lysates
propagating the m.d. high [RNQ+] variant consistently showed
higher starting concentrations of the Rnq1 protein, likely because
the very thermal stable Rnq1 aggregates of s.d. [RNQ+] were not
completely broken down.
Immunoprecipitation
For co-immunoprecipitation of Sis1 and Rnq1, cultures were
grown overnight, washed, and lysed by vortexing in buffer
(50 mM Tris pH 8, 150 mM NaCl, 1 mM EDTA, 0.2% Triton
X-100, 1 mM PMSF, 50 mM NEM, complete protease inhibitor
from Roche) containing glass beads. Lysates were pre-cleared by
centrifugation at 9,300g for 30 sec at 4uC. Protein was normalized
to 1 mg/mL. Following incubation with or without aSis1
antibodies for 1 hr at 4uC, Protein G Sepharose (GE Healthcare)
beads were added and incubated for 1 hr at 4uC. Beads were
pelleted by centrifugation at 800g for 30 sec, followed by washing
three times, and boiling at 100uC for 5 min. Samples were
analyzed by SDS-PAGE and western blot using aRnq1 and aSis1
antibodies.
Phenotypic colorimetric assays
Taking advantage of the ability of [RNQ+] cells harboring RRP
to suppress ade1-14, we monitored [RRP+] phenotypes as done
previously [33]. Equal numbers of cells were normalized by
OD600, serially diluted five-fold, and spotted to the indicated
media. SD-ade plates were incubated at 30uC for 6 days, while all
other types of media were incubated for 3 days, followed by
overnight at 4uC for color development. Mitotic stability assays
were performed as before with at least three independent cultures
for each [RNQ+] variant [34].
Joining assay
Cells were transformed with pYES2-GAL-HA-RNQ1 or pYES2-
GAL-RNQ1(153-405). Overnight cultures grown in glucose-based
selection media were washed and diluted to OD600 0.3 in
induction media containing 2% galactose+1% raffinose, followed
by harvesting after 3 hrs of growth. Cell lysates were prepared and
analyzed by well-trap assay.
[PSI+] formation
To monitor the spontaneous conversion to [PSI+], cells were
first transformed with pRS414GPD-SIS1 or an empty vector
control. Then, using suppression of ade1-14 to monitor [PSI+]
formation, at least three independent cultures were grown
overnight and 200 ml of culture was plated on SD-ade-trp and
200 ml of a 1:10,000 dilution was plated on SD-trp. SD-ade-trp
plates were grown overnight at 30uC, followed by two weeks at
4uC, then two weeks at 30uC, as it has been reported that cold
enhances prion formation [40]. To calculate the number of cells
plated on SD-ade-trp, the colonies on SD-trp were counted,
averaged, and multiplied by the dilution factor of 10,000. Over
7.16106 cells were plated on SD-ade-trp for each condition. Ade+
colonies were then scored as [PSI+] by spotting to YPD and SD-
ade, as well as YPD+3 mM GdnHCl to confirm curability. The
rate of [PSI+] formation was then calculated as the ratio of [PSI+]
colonies to the total number of cells plated.
The induction of [PSI+] by over-expression of Sup35 was
performed as previously described [33]. Briefly, cells expressing
the indicated Rnq1 construct were transformed with pEMBL-
SUP35. Overnight cultures were normalized by OD600 and
spotted in five-fold serial dilutions to SD-his, SD-ade, and SD-
ade-his. At least five independent experiments were performed. As
previously reported, over 88% of colonies are bona fide [PSI+]
[49].
Supporting Information
Figure S1 Differential proteinase K resistance of Rnq1 in
[RNQ+] variants. Rnq1 aggregates of the m.d. high [RNQ+]
variant reproducibly show enhanced protease resistance as
compared to s.d. [RNQ+] variants. Lysates of cells propagating
the indicated [RNQ+] variant were incubated with a gradient of
different proteinase K (PK) concentrations at 37uC for 30 min,
followed by SDS-PAGE and western blot analysis using an aRnq1
antibody.
(TIF)
Figure S2 Inviability of FL RRP in m.d. high [RNQ+] cells
depends on Rnq1 expression. Cultures of three different clones of
rnq1D cells propagating m.d. high [RNQ+], along with controls of
[rnq2] cells, cells cured of m.d. high [RNQ+], and m.d. high
[RNQ+] cells, all expressing FL RRP were normalized by OD600,
serially diluted five-fold, and spotted on media to select for loss (2
Sup35) or co-expression (+ Sup35) of wild-type Sup35. Represen-
tative spottings are shown.
(TIF)
Figure S3 Expression of FL RRP in cells propagating s.d.
[RNQ+] variants. Cultures of [rnq2] cells or cells propagating s.d.
low, s.d. medium, or s.d. very high [RNQ+] and expressing Sup35,
RRP, or full-length (FL) RRP were normalized by OD600, serially
diluted five-fold, and spotted to select for loss (2 Sup35) or co-
expression (+ Sup35) of wild-type Sup35. Representative spottings
are shown.
(TIF)
Figure S4 Protein expression of Rnq1 alanine mutants.
Normalized protein from cell lysates expressing the indicated
Rnq1 alanine mutant, or an empty vector (EV), in place of WT
Rnq1, was subjected to SDS-PAGE and western blot using an
aRnq1 antibody.
(TIF)
Figure S5 Summary of effects on [RNQ+] propagation by
mutation of Rnq1 amyloidogenic regions according to assay. For
the indicated assay, mutants are categorized as having no effect
(white), mild effect (yellow), moderate effect (orange), or not
propagating [RNQ+] (red) after successive passaging. (A) Examples
of how the Rnq1 solubility assay was scored. Cells propagating
m.d. high [RNQ+] (m.d.), s.d. low [RNQ+] (Low), or s.d. very high
[RNQ+] (VH), and harboring either wild-type (WT) Rnq1 or the
indicated Rnq1 alanine mutant, were fractionated by high-speed
ultracentrifugation into total (T), supernatant (S), and pellet (P)
fractions, followed by SDS-PAGE and western blot using an
aRnq1 antibody. Mutants were characterized as follows: 1) mild
effect, if there was a slight increase in the amount of soluble Rnq1;
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2) moderate effect, if the supernatant and pellet fractions
contained roughly equal amounts of Rnq1; or 3) cured, if all of
Rnq1 accumulated in the supernatant. (B) Examples of how the
thermal stability of Rnq1 aggregates was scored. Cells propagating
the indicated [RNQ+] variant with either WT Rnq1 or the
indicated Rnq1 alanine mutant were lysed and treated with a
temperature gradient, followed by SDS-PAGE and western blot
using an aRnq1 antibody. Mutants were characterized as follows:
1) mild effect, if there was a slight, but reproducible shift in the
more intense bands; 2) moderate effect, if the number of intense
bands shifted by four or more lanes; 3) cured, if there was roughly
equal amounts of Rnq1 in each lane, which was confirmed by
well-trap assay; or 4) more stable, if Rnq1 was reproducibly
present in fewer lanes. (C) Summary table of the effects of Rnq1
mutants on [RNQ+] propagation. Unless the phenotypic change is
noted, colors indicate: decreased aggregate densitometry (SDD-
AGE), decreased stability (Thermal stability), or increased pool of
soluble Rnq1 (Solubility assay). Data are summarized from at least
three independent experiments.
(TIF)
Figure S6 Disruption of Rnq1 amyloidogenic regions eliminates
propagation of [RNQ+] variants. Cells originally propagating the
indicated [RNQ+] variant and expressing WT Rnq1 or a Rnq1
alanine mutant from a HIS-marked plasmid (as in Figure 4) were
transformed with a RNQ1 URA3-marked plasmid. These cells were
then screened for loss of the indicated Rnq1 construct in order to
express WT Rnq1 from the URA3-marked plasmid as the only
copy of Rnq1. For instance, P-WT and P-A3 refer to post (P)
expression of the HIS-marked copy of WT Rnq1 and Rnq1-A3,
respectively, and now both expressing WT Rnq1. The presence of
Rnq1 aggregates in these Ura+ his- cells was then monitored using
SDD-AGE and western blot using an aRnq1 antibody.
(TIF)
Figure S7 Expression levels of Ssa and Hsp104 are unchanged
when Sis1 is over-expressed. Cells with the indicated [RNQ+]
status were transformed with a Sis1 over-expressing plasmid (+) or
an empty vector control (2). Lysates were subjected to SDS-
PAGE and western blot using aHsp104, aHsp70-Ssa, aSis1, and
aPgk1 antibodies.
(TIF)
Figure S8 Formation of [PSI+] is altered by mutation of Rnq1
amyloidogenic regions. [rnq2] cells or cells propagating the
indicated [RNQ+] variant and expressing WT Rnq1 or mutants
(A) A2, (B) A3, (C) A4, (D) A5, (E) A6, (F) A8, (G) A10, or (H) A11
were transformed with a plasmid over-expressing Sup35. [PSI+]
induction was monitored by spotting five-fold serial dilutions of
normalized numbers of cells on SD-ade and SD-ade-his.
Representative spottings from at least five independent experi-
ments are shown.
(TIF)
Table S1 Yeast strains used in this study.
(DOC)
Table S2 Plasmids used in this study.
(DOC)
Table S3 Oligonucleotides used in this study.
(DOC)
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